Running a business often feels like managing an equation with too many unknown factors. While most executives rely on intuition or simple rules of thumb to make decisions, small changes to customer acquisition or supply costs can trigger unexpected outcomes across an entire organization. Dr. Finith Jernigan, who transitioned from molecular design and drug discovery into science-based business acquisition, sees these operational hurdles through the lens of a lab scientist. Instead of relying on gut feelings, he argues that artificial intelligence gives leaders the power to map out complex, multivariate business problems and track how different inputs actually shape the bottom line.
Breaking Down the Multivariate Business Equation
In any growing firm, executive teams routinely juggle multiple operational inputs in hopes of driving revenue and expanding profit margins. For human managers, keeping tabs on how each independent variable affects the company as a whole quickly turns into an administrative headache. “Usually, there are multiple inputs resulting in multiple outputs,” Jernigan points out. Because conventional business wisdom tends to look at problems in isolation, leaders often miss how different operational levers push and pull against each other behind the scenes.
This challenge grows even steeper when those relationships stop behaving in a straight, predictable line. Drawing on his scientific background, Jernigan compares modern business operations to combination drug therapies, in which several compounds must work together at exact dosages to yield a specific medical result. “A lot of times, if you double an input, you don’t get double the output; you get four times the output in either direction by doubling an input,” he explains. By feeding these variables into computational models, companies can uncover hidden nonlinear patterns that experience alone would never catch.
Applying Scientific Rigor to Emerging Technology
Despite the widespread rush to roll out new software tools, many pilot programs fail before ever reaching full deployment. Jernigan sees clear parallels between today’s corporate technology rollout and past trends in life sciences, where heavily marketed platforms rarely produced practical treatments. “The number of times I’ve heard, even in my relatively brief career, ‘We’re going to transform drug discovery,’ and then you see the outputs and realize nothing was really produced from this supposedly revolutionary platform,” he recalls. In his assessment, introducing automated tools without a clear evaluation framework only creates expensive distractions.
To prevent wasted capital, Jernigan advocates bringing the discipline of scientific hypothesis testing into executive decision-making. Far too often, project teams realize an initiative is falling short and quietly shift their definition of success midway through the process. “Develop a hypothesis, figure out what you expect to see, and then go through and ask if you are actually seeing what you said at the beginning,” Jernigan suggests. Maintaining that degree of honesty keeps companies from claiming false victories and helps leaders redirect resources toward initiatives that genuinely move the needle.
Shifting From Intuition to Measured Optimization
Before a company can build sophisticated analytical models, it must first gain basic visibility into everyday performance numbers. Surprisingly, many business owners still struggle to pull simple, cohesive metrics out of fragmented inventory and accounting platforms. Jernigan considers automated data consolidation the most practical starting point for any leadership team looking to modernize. Getting fast and reliable answers to routine operational questions frees decision-makers from digging through spreadsheets and gives them the clean foundation required for higher-level analysis. With reliable metrics in place, leadership teams can begin testing their foundational assumptions rather than running the business on habit.
Instead of trying to fix everything at once, Jernigan recommends applying computational analysis directly to high-impact priorities first. “You can simplify driving to the goal by getting at the actual drivers of the result,” he explains. Isolating the true chain of causation allows executives to confirm whether their strategic instincts hold up against hard evidence.
Ultimately, the value of artificial intelligence lies not in the sophistication of the algorithm but in how thoroughly an organization tests its systems. When executives get bogged down in daily firefighting, they often lose sight of the primary drivers that control their long-term objectives. Setting clear benchmarks and continuously measuring results give leaders the clarity needed to navigate complex market conditions. By treating company strategy with the same rigor found in scientific research, businesses can replace reactive guesswork with steady, predictable performance.
Follow Dr. Finith Jernigan on LinkedIn for more insights on applying scientific rigor, computational models, and data-driven optimization to business operations.